Navigation Links
Micromet, Inc. To Regain Rights to Blinatumomab in North America; Reports Financial Results for the Fourth Quarter and Full Year ended December 31, 2008
Date:3/12/2009

res issued and outstanding at December 31, 2008 and December 31, 2007, respectively 2 2 Additional paid-in capital 227,806 184,014 Accumulated other comprehensive income 5,749 5,895 Accumulated deficit (198,169) (164,933) Total stockholders´ equity 35,388 24,978 Total liabilities and stockholders' equity $70,675 $56,252
    Micromet, Inc.
    Condensed Consolidated Statements of Operations 
    (In thousands, except per share amounts)
    (Unaudited)

                                  Three Months Ended    Year Ended
                                     December 31,      December 31,
                                    2008     2007     2008     2007

    Revenues
        Collaboration agreements  $5,212   $6,751   $25,870   $17,366
        License fees and other       660      234     1,416     1,018
    Total revenues                 5,872    6,985    27,286    18,384
    Operating expenses
        Research and development   8,534    9,471    39,189    29,191
        General and administrative 3,817    3,590    14,163    14,430
    Total operating expenses      12,351   13,061    53,352    43,621
    Loss from operations          (6,479)  (6,076)  (26,066)  (25,237)
    Other income (expense)
        Interest expense             (33)     (71)     (222)     (509)
        Interest income               91      348       740       938
        Change in fair value of
         warrants                    439       41    (8,064)    1,750
        Other income                 131    1,817       377     2,932
    Net loss                     $(5,851) $(3,799) $(33,235) $(20,126)
    Basic and diluted net
     loss per common share        $(0.12)  $(0.09)   $(0.77)   $(0.55)
    Weighted average shares
     used to compute basic
     and 
'/>"/>
SOURCE Micromet, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related biology technology :

1. Micromet, Inc. Reports Third Quarter 2008 Financial Results
2. Micromet, Inc. to Host Conference Call and Webcast to Discuss Third Quarter 2008 Financial Results
3. Micromet, Inc. Fills Audit Committee Vacancy and Regains Compliance With NASDAQ Marketplace Rule
4. Micromet, Inc. Appoints Barclay Phillips as Senior Vice President and Chief Financial Officer
5. Micromet, Inc. Reports Fourth Quarter and Full Year 2007 Financial Results
6. Micromet, Inc. to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2007 Financial Results
7. Micromet, Inc. Elects Joseph P. Slattery to Board of Directors
8. Micromet, Inc. to Present at the Sal. Oppenheim 2nd European Healthcare Conference
9. Verenium Regains Compliance With Nasdaq Continued Listing Requirement
10. Peregrine Pharmaceuticals Receives Additional Time to Regain Compliance With NASDAQs Minimum Bid Price Rule
11. Peregrine Pharmaceuticals Receives Letter from NASDAQ Citing Failure to Regain Compliance with Minimum Bid Price Rule
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/30/2014)... (PRWEB) September 30, 2014 Proove ... medicine, is excited to announce a new genetic test ... The Proove Pain Perception Test will provide physicians ... and why pain tolerance levels are stratified between individuals. ... identify whether a person has a genetic predisposition that ...
(Date:9/30/2014)... 2014  RegeneRx Biopharmaceuticals, Inc. (OTC: RGRX) ("the ... received a Canadian Patent for Inhibition or Reversal ... includes claims using thymosin beta 4, various fragments ... these purposes.  The patent will expire in 2021. ... www.regenerx.com ) RegeneRx is focused ...
(Date:9/30/2014)... Fast, semi-automatic creation of ... documents ChemAxon , a leader ... for life science research, launches ChemCurator, an application ... from documents. Markush structures are essential ... and understanding Markush structures is a difficult and ...
(Date:9/30/2014)... Los Angeles, CA (PRWEB) September 30, 2014 ... Separation (EWS), the high-speed, chemical-free process to clean up ... letter to shareholders, CEO Riggs Eckelberry reported on the ... West Texas, at a site provided by partner ... ramped up to 1000 barrels per day (bpd) and ...
Breaking Biology Technology:Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 2Proove Biosciences is Now Offering the Proove Pain Perception Genetic Test to Help Physicians Assess Patient Pain Tolerance Levels 3RegeneRx Receives Canadian Patent for Inhibition or Reversal of Skin Aging 2ChemAxon Introduces ChemCurator for Chemical Information Extraction and Markush Structure Creation 2OriginOil, Inc. Report to Shareholders: Blue Gold in West Texas 2
... BEACH, Calif. & HAMILTON, New Zealand, Oct. 29 ... for DNA extraction and other life sciences applications, today ... VERITAS Japan to distribute ZyGEM,s DNA extraction products to ... latest in a series of recent major distribution agreements ...
... MATEO, Calif., Oct. 29 NeurogesX, Inc. (Nasdaq: ... commercializing novel pain management therapies, announced today that Anthony ... present at two upcoming conferences in New York City: ... be held November 3-4, 2009 and the Lazard Capital ...
... ... Access IR/PR, a San Diego-based investor and public relations ... consultancy based in Boston, have formed a strategic alliance. The alliance ... and provides extended access to key financial, investor and media communities ...
Cached Biology Technology:ZyGEM Strengthens its Worldwide Presence With New Distribution Agreement for Japan 2ZyGEM Strengthens its Worldwide Presence With New Distribution Agreement for Japan 3ZyGEM Strengthens its Worldwide Presence With New Distribution Agreement for Japan 4NeurogesX to Present at Two November Conferences 2NeurogesX to Present at Two November Conferences 3Investor Relations Firm Access IR/PR and The Communications Strategy Group Announce Strategic Alliance 2
(Date:9/30/2014)... led by Clemson University associate professor Brian Powell, ... the U.S. Department of Energy,s Experimental Program to ... impact on South Carolina in the advancement of ... "Understanding the scientific and engineering needs for safely ... technologies is imperative if South Carolina is to ...
(Date:9/30/2014)... can live in almost any aquatic environment on Earth, ... many species are pushed to the limit. The amount ... prove critical for how different species cope in the ... University of Gothenburg, published in the scientific journal ... change continues apace thanks to increasing levels of greenhouse ...
(Date:9/30/2014)... When it comes to using marijuana, new research, involving ... the Journal of Leukocyte Biology , ... mean that you should. That,s because a team of ... may do serious long-term damage to the immune system. ... inflammatory diseases, such as multiple sclerosis, inflammatory bowel disease ...
Breaking Biology News(10 mins):Researchers get $5.25 million to advance nuclear technologies in South Carolina 2Shape up quickly -- applies to fish, too! 2Adolescent exposure to thc may cause immune systems to go up in smoke 2
... up to 1000 times larger than their wild relatives. ... food plants have larger fruits, heads of grain, tubers, etc, ... chose when foraging for food. In addition to size, ... nutrient composition, but it has been difficult to study these ...
... BOZEMAN Two Montana state University researchers are principal ... find noninvasive ways to study carnivores in the wild. ... was released June 27 with Robert Long and Paula ... at MSU,s Western Transportation Institute. Working with ...
... at UT Southwestern Medical Center have determined that starvation ... that may have implications in treating diabetes and extending ... blunted during starvation. But our work shows that this ... much more sophisticated than that," said Dr. Steven Kliewer, ...
Cached Biology News:Evolution of fruit size in tomato 2Evolution of fruit size in tomato 3Growth hormone's link to starvation may be clue to increasing life span, researchers find 2
Hucal Agx Antigen Expression Service Specificity: Hucal Agx ...
MHC. Sections include: the isolation and functional properties of antigen-presenting cells analysis of MHC class II endocytosis and peptide turnover analysis of signalling via MHC class II molecu...
... The 1-D PAGE ... Kit for Targeted Protein ... SDS PolyAcrylamide Gel Electrophoresis ... chemistry, and cleavable-linker technology ...
Supplemental reagent for annexin V assay....
Biology Products: